EuroGTP II: a tool to assess risk, safety and efficacy of substances of human origin

Int J Qual Health Care. 2020 Apr 21;32(1):80-84. doi: 10.1093/intqhc/mzz048.

Abstract

A systematic methodology, able to assess risk and predict clinical safety and efficacy of Substances of Human Origin' (SoHO) has been developed. The model consists of a risk based approach taking into account factors such as novelty of the product, preparation process, clinical indication, and its technical complexity.

Keywords: clinical efficacy; risk assessment; risk factors; translational medical research.

MeSH terms

  • Cell- and Tissue-Based Therapy / standards*
  • European Union
  • Humans
  • Risk Assessment / methods*
  • Risk Factors
  • Translational Research, Biomedical
  • Treatment Outcome